Sponsor or institution
Clinical trials and research at Tega Therapeutics, INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $1.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Recombinant heparin made in cells to reduce HIT
A new, cell-made heparin variant is being tested to lower the risk of HIT while providing effective blood-thinning.
-
Developing a new way to produce heparin using engineered cells
This study is working on a new way to make heparin, a medicine that helps prevent blood clots, using specially designed cells, so that patients can have a safer and more reliable supply without relying on animals.
-
Developing a treatment for GM1 gangliosidosis
This study is looking at a new way to help people with GM1 gangliosidosis by testing a special treatment that delivers a missing enzyme directly to the brain, hoping to make life better for those dealing with the challenges of this condition.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.